相关实验视频

Updated: Jun 21, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

基于RNase H敏感的多功能ASO构造作为治疗多因素复杂病理的有希望的工具

Aida Mata-Ventosa¹, Ariadna Vila-Planas², Aina Solsona-Pujol³

¹Molecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine, University of Barcelona (IBUB), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBER EHD), Instituto de Salud Carlos III, Madrid, Spain; Institut de Recerca Sant Joan de Déu (IR SJD-CERCA), Esplugues de Llobregat, Barcelona, Spain.

Bioorganic chemistry

|July 5, 2024

概括

研究人员开发了一种新的RNase H-敏感构造 (3ASO),用于同时输送三种治疗性寡核酸 (ON). 这种方法显示出对HER2+乳腺癌细胞的低毒性和抗增殖活性,为复杂疾病提供了新的策略.

科学领域:

分子生物学分子生物学
药物输送系统药物输送系统
在瘤学瘤学.

背景情况:

组合疗法对于治疗癌症等复杂疾病至关重要,但目前的药物组合往往会导致毒性.
通过补偿通路激活,可以规避向疗法,需要创新的治疗策略.

研究的目的:

设计和评估一种新型类型的RNase H-敏感结构 (3ASO),用于同时在细胞内释放多个治疗性寡核酸 (ON).
研究RNase H1.1对这些结构的识别和分离机制.
评估3ASO在HER2+乳腺癌细胞中向HER2,Akt和Hsp27的疗效和毒性.

主要方法:

对RNase H.敏感的RNA·DNA混合结构 (3ASO) 的设计.
利用大肠杆菌RNase H1来研究结构识别和分离机制.
创建了针对 HER2,Akt 和 Hsp27 mRNA 在 HER2+ 乳腺癌细胞中的 3ASO 结构.
在体外 (in vitro) 评估了抗增殖活性和毒性.

主要成果:

展示了由构造拓学决定的RNase H识别和分离的前所未有的模式.
3ASO构造有效地同时提供三种不同的治疗性寡核酸.
在HER2+乳腺癌细胞中表现出低毒性和显著的抗增殖活性.

结论:

开发的3ASO技术能够有效地单剂量同时给多种ON药物.
这种方法在治疗具有多个mRNA标的复杂病理方面具有重大潜力,克服了当前组合疗法的局限性.

关键词:

3ASO是一个多目标工具.反意义的寡核化物.癌症癌症癌症癌症复杂的病理复杂的病理这就是RNase H.刺激对刺激的反应性.

更多相关视频

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

相关概念视频

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...